Glendale, CO, United States of America

Meiqin Wang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Contributions of Inventor Meiqin Wang in Allergy Research

Introduction: Meiqin Wang is a distinguished inventor based in Glendale, Colorado, known for her impactful contributions to the field of allergy treatment. With a total of four patents, her research focuses on innovative methods to address allergic conditions through new therapeutic approaches.

Latest Patents: Among her latest patents are methods to treat allergic conditions using PIM1 kinase inhibitors. This invention discloses methods for treating both pulmonary and non-pulmonary allergic conditions by administering a composition that inhibits Pim kinase. Additionally, she has developed methods to treat allergic conditions by inducing the expression of Runx3. Wang's work also includes targeting the steroidogenic pathway for treating and/or preventing allergic diseases, which involves compositions and methods aimed at inhibiting components of this pathway.

Career Highlights: Meiqin Wang is currently affiliated with National Jewish Health, where she advances her research on allergies and their treatment. Her innovations are pivotal in finding new solutions for patients suffering from allergic conditions.

Collaborations: Throughout her career, Wang has collaborated with renowned colleagues, including Erwin W. Gelfand and Yi Jia. These professional relationships have contributed significantly to her research and its application in clinical settings.

Conclusion: Meiqin Wang stands out as an influential inventor in the allergy treatment landscape. Her patented inventions pave the way for innovative therapeutic strategies, highlighting her commitment to improving patient care and advancing medical research in allergy treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…